Myotonia congenita and myotonic dystrophy: surveillance and management.
about
The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker.Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses.Paroxysmal kinesigenic dyskinesia and myotonia congenita in the same family: coexistence of a PRRT2 mutation and two CLCN1 mutationsOral motor movements and swallowing in patients with myotonic dystrophy type 1.
P2860
Myotonia congenita and myotonic dystrophy: surveillance and management.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Myotonia congenita and myotonic dystrophy: surveillance and management.
@en
Myotonia congenita and myotonic dystrophy: surveillance and management.
@nl
type
label
Myotonia congenita and myotonic dystrophy: surveillance and management.
@en
Myotonia congenita and myotonic dystrophy: surveillance and management.
@nl
prefLabel
Myotonia congenita and myotonic dystrophy: surveillance and management.
@en
Myotonia congenita and myotonic dystrophy: surveillance and management.
@nl
P2860
P1476
Myotonia congenita and myotonic dystrophy: surveillance and management.
@en
P2093
Allison Conravey
Lenay Santana-Gould
P2860
P2888
P356
10.1007/S11940-009-0055-Z
P577
2010-01-01T00:00:00Z